A European Study on First-Line Treatment of Metastatic Kidney Cancer

CARE1 is focused on pragmatic clinical trials, it aims to improve the first-line treatment for patients with metastatic kidney cancer by implementing a routine biomarker, leveraging a unique academic network in Europe.

1,200

Patients

8+

Countries

100

Participating hospitals in Europe

7+

Associated research programs
bio-me

CARE1 in a few words

Focused on pragmatic clinical trials, CARE1 is an European project aiming to improve the first-line treatment for patients with metastatic kidney cancer by implementing a routine biomarker, leveraging a unique academic network in Europe.

See more

Outcome

CARE1 was designed to determine the optimal combination for patients using a routine implementable biomarker. CARE1 will establish a large-scale platform to define the best standard of treatment based on a routine biomarker to enhance treatment efficacy. In the long term, a data collection effort, including the creation of a pathological and blood biobank, will be conducted on a European scale.

See more

Innovation

This project also aims to innovate healthcare, patient care and research by exploring the use of AI in diagnostics and clinical research, and the use of digital tools for patient care.

See more

Our latest articles

To view more, visit our Blog page


Kudos for the new #CARE1 ...
2024-05-01 • 
Kudos for the new #CARE1 ...

Such a crystal clear, thoughtful approach to doublets from @AlbigesL as front line for metastatic #kidneycancer! Doublets are now established standard in trials AND the need for biomarkers for future patient/tx selection. Kudos for the new #CARE1 trial underway in EU! #ASCO23...

Read more
CARE1_Kick-off Meeting...
2024-05-01 • 
CARE1_Kick-off Meeting...

"« We are pleased to announce the launch of #CARE1 Project, which officially started on May 1st, 2023. The project was submitted under the Call HORIZON-MISS-2022-CANCER-01-03, focused on pragmatic clinical trials to optimize treatments for patients with refractory cancers. ...

Read more
📢 Launch of the pragmatic...
2024-05-01 • 
📢 Launch of the pragmatic...

📢 Launch of the pragmatic CARE-1 ​​clinical trial coordinated by Pr @AlbigesL @GustaveRoussy. A key step in the future of kidney cancer care #CARE1 #ClinicalResearch #HealthCareInnovation @HorizonEU...

Read more
CARE1 at the 1st Horizon ...
2024-10-09 • 
CARE1 at the 1st Horizon ...

Our CARE1 team was represented on site by the Project ...

Read more

Agenda

May 2023
  • Project start date
April 2024 in France
  • Start of the trial
May 2024
  • First General Assembly #1
September 2024
  • Trial start in Czech Republic
TBA
  • Trial start in Netherlands, Austria, United Kindgom, Italy and Germany
May 2025
  • Second General Assembly #2
May 2026
  • Third General Assembly #3
May 2027
  • Fourth General Assembly #4

Partners

Contact us

For further questions, including partnership opportunities, please contact using our contact form.

Follow us on social media